Baby TAM’ is a good bet to prevent breast cancer after DCIS, but the effects are different before and after menopause.

Plexus Corp. (NASDAQ: PLXS) today announced the release of its Fiscal 2025 Sustainability Report. The report, which is now available on the Sustainability page of plexus.com, marks a significant ...

Ivonescimab reduced the risk of death by one-third compared to chemotherapy in a China-based study that’s seen as an ...

Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...

Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...

Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the first quarter of 2026 investor letter. A copy of the letter can be downloaded here. The ...

Durvalumab monotherapy did not meet the prespecified statistical threshold for DFS versus active monitoring, despite a 6-point absolute 3-year DFS difference (78% vs 72%). RAMPART enrolled ...

The delayed implementation of the model in Medicare gives CMS, plans, and manufacturers an opportunity to address key ...

Innocenzo Cipolletta, economist, former director general of Confindustria and now president of the Italian Association of ...

Goldman Sachs 30th Annual European Financials Conference 2026 June 4, 2026 2:00 AM EDTCompany ParticipantsWilliam ...

Higher rates of adverse events offset the positive survival results in an area of great unmet need. For decades, the standard ...